US3133967A - 1-(3, 4-dialkoxy-phenol)-1-dialkylamino-3-and-4-piienyl butanes - Google Patents
1-(3, 4-dialkoxy-phenol)-1-dialkylamino-3-and-4-piienyl butanes Download PDFInfo
- Publication number
- US3133967A US3133967A US6622A US662260A US3133967A US 3133967 A US3133967 A US 3133967A US 6622 A US6622 A US 6622A US 662260 A US662260 A US 662260A US 3133967 A US3133967 A US 3133967A
- Authority
- US
- United States
- Prior art keywords
- phenyl
- methoxy
- phenyd
- ethoxy
- butane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical class CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 title description 11
- 235000013844 butane Nutrition 0.000 title 1
- ZBLHFVBETMYTIM-UHFFFAOYSA-N 1-(4-ethoxy-3-methoxyphenyl)-N,N-dimethyl-4-phenylbutan-1-amine Chemical compound C(C)OC1=C(C=C(C=C1)C(CCCC1=CC=CC=C1)N(C)C)OC ZBLHFVBETMYTIM-UHFFFAOYSA-N 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 61
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 61
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Substances CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 50
- -1 morpholyl Chemical group 0.000 description 45
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 44
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 42
- 150000001875 compounds Chemical class 0.000 description 40
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 36
- 239000000203 mixture Substances 0.000 description 23
- 229930008281 A03AD01 - Papaverine Natural products 0.000 description 22
- 229960001789 papaverine Drugs 0.000 description 22
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 21
- 239000000243 solution Substances 0.000 description 19
- 239000001273 butane Substances 0.000 description 18
- OCKPCBLVNKHBMX-UHFFFAOYSA-N n-butyl-benzene Natural products CCCCC1=CC=CC=C1 OCKPCBLVNKHBMX-UHFFFAOYSA-N 0.000 description 18
- ODLMAHJVESYWTB-UHFFFAOYSA-N ethylmethylbenzene Natural products CCCC1=CC=CC=C1 ODLMAHJVESYWTB-UHFFFAOYSA-N 0.000 description 16
- 238000000034 method Methods 0.000 description 15
- 239000012071 phase Substances 0.000 description 15
- 150000003512 tertiary amines Chemical class 0.000 description 15
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 14
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
- 238000009835 boiling Methods 0.000 description 14
- 239000001294 propane Substances 0.000 description 13
- 230000002048 spasmolytic effect Effects 0.000 description 12
- 150000004795 grignard reagents Chemical class 0.000 description 11
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 11
- 239000011541 reaction mixture Substances 0.000 description 11
- 239000007818 Grignard reagent Substances 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 9
- 125000004432 carbon atom Chemical group C* 0.000 description 9
- 238000002844 melting Methods 0.000 description 9
- 230000008018 melting Effects 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 229910021529 ammonia Inorganic materials 0.000 description 7
- 239000011260 aqueous acid Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 150000002825 nitriles Chemical class 0.000 description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
- 239000000812 cholinergic antagonist Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 239000011777 magnesium Substances 0.000 description 6
- 229910052749 magnesium Inorganic materials 0.000 description 6
- 231100000252 nontoxic Toxicity 0.000 description 6
- 230000003000 nontoxic effect Effects 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 241000700199 Cavia porcellus Species 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 5
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 5
- 229910001626 barium chloride Inorganic materials 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 238000001953 recrystallisation Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 4
- 208000007101 Muscle Cramp Diseases 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 4
- 125000003545 alkoxy group Chemical group 0.000 description 4
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 4
- 229940073608 benzyl chloride Drugs 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 210000001072 colon Anatomy 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- WMPPDTMATNBGJN-UHFFFAOYSA-N 2-phenylethylbromide Chemical compound BrCCC1=CC=CC=C1 WMPPDTMATNBGJN-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 230000003444 anaesthetic effect Effects 0.000 description 3
- 150000001649 bromium compounds Chemical class 0.000 description 3
- 230000000916 dilatatory effect Effects 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 150000004694 iodide salts Chemical class 0.000 description 3
- 239000003589 local anesthetic agent Substances 0.000 description 3
- GZUXJHMPEANEGY-UHFFFAOYSA-N methyl bromide Substances BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 3
- VTFLIYPNOKEFRW-UHFFFAOYSA-N n,n-dimethyl-4-phenylbutan-1-amine Chemical compound CN(C)CCCCC1=CC=CC=C1 VTFLIYPNOKEFRW-UHFFFAOYSA-N 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 230000000304 vasodilatating effect Effects 0.000 description 3
- AFSSHNZSNXLDNU-UHFFFAOYSA-N 1-(2,3-dimethoxyphenyl)-N,N-dimethyl-4-phenylbutan-1-amine Chemical compound COC1=CC=CC(C(CCCC=2C=CC=CC=2)N(C)C)=C1OC AFSSHNZSNXLDNU-UHFFFAOYSA-N 0.000 description 2
- SRKJRPFCSZFVAE-UHFFFAOYSA-N 1-(3,4-dimethoxyphenyl)-n,n-dimethyl-4-phenylbutan-1-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1C(N(C)C)CCCC1=CC=CC=C1 SRKJRPFCSZFVAE-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 150000003840 hydrochlorides Chemical class 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940102396 methyl bromide Drugs 0.000 description 2
- 230000000956 myotropic effect Effects 0.000 description 2
- ITMSSZATZARZCA-UHFFFAOYSA-N n-ethyl-n-phenylaniline Chemical class C=1C=CC=CC=1N(CC)C1=CC=CC=C1 ITMSSZATZARZCA-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- LNCZCZGSBAUDQJ-UHFFFAOYSA-N 1-(4-ethoxy-3-methoxyphenyl)-N,N-dimethyl-4-phenylbutan-1-amine hydrochloride Chemical compound Cl.C(C)OC1=C(C=C(C=C1)C(CCCC1=CC=CC=C1)N(C)C)OC LNCZCZGSBAUDQJ-UHFFFAOYSA-N 0.000 description 1
- GIIMZQBLEYMJHK-UHFFFAOYSA-N 1-(4-phenylbutyl)pyrrolidine Chemical compound C1CCCN1CCCCC1=CC=CC=C1 GIIMZQBLEYMJHK-UHFFFAOYSA-N 0.000 description 1
- WGVYCXYGPNNUQA-UHFFFAOYSA-N 1-(bromomethyl)-2-methylbenzene Chemical compound CC1=CC=CC=C1CBr WGVYCXYGPNNUQA-UHFFFAOYSA-N 0.000 description 1
- WZRKSPFYXUXINF-UHFFFAOYSA-N 1-(bromomethyl)-4-methylbenzene Chemical compound CC1=CC=C(CBr)C=C1 WZRKSPFYXUXINF-UHFFFAOYSA-N 0.000 description 1
- UOTMYNBWXDUBNX-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinolin-2-ium;chloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 UOTMYNBWXDUBNX-UHFFFAOYSA-N 0.000 description 1
- KPABPCBOQKQQON-UHFFFAOYSA-N 1-[1-(4-methoxy-3-methylphenyl)-2-phenylethyl]piperidine Chemical compound COC1=C(C=C(C=C1)C(CC1=CC=CC=C1)N1CCCCC1)C KPABPCBOQKQQON-UHFFFAOYSA-N 0.000 description 1
- HLVFKOKELQSXIQ-UHFFFAOYSA-N 1-bromo-2-methylpropane Chemical compound CC(C)CBr HLVFKOKELQSXIQ-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- XHOXKVFLASIOJD-UHFFFAOYSA-N 1-phenylbutan-1-amine Chemical compound CCCC(N)C1=CC=CC=C1 XHOXKVFLASIOJD-UHFFFAOYSA-N 0.000 description 1
- 125000001617 2,3-dimethoxy phenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- LTFGKABZWKBQEX-UHFFFAOYSA-N 2-(2-ethoxyphenyl)-2-piperidin-1-ylacetonitrile Chemical compound CCOC1=CC=CC=C1C(C#N)N1CCCCC1 LTFGKABZWKBQEX-UHFFFAOYSA-N 0.000 description 1
- YOWLINZASNDMHX-UHFFFAOYSA-N 2-(3,4-diethoxyphenyl)-2-(dimethylamino)acetonitrile Chemical compound CCOC1=CC=C(C(C#N)N(C)C)C=C1OCC YOWLINZASNDMHX-UHFFFAOYSA-N 0.000 description 1
- JZLHTOLMOXPZPY-UHFFFAOYSA-N 2-(dibutylamino)-2-(3,4-dimethoxyphenyl)acetonitrile Chemical compound COC=1C=C(C=CC1OC)C(C#N)N(CCCC)CCCC JZLHTOLMOXPZPY-UHFFFAOYSA-N 0.000 description 1
- ZYBQTYQZYRFXMV-UHFFFAOYSA-N 2-(diethylamino)-2-(2,3-dimethoxyphenyl)acetonitrile Chemical compound CCN(CC)C(C#N)C1=CC=CC(OC)=C1OC ZYBQTYQZYRFXMV-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- XMZQWZJMTBCUFT-UHFFFAOYSA-N 3-bromopropylbenzene Chemical compound BrCCCC1=CC=CC=C1 XMZQWZJMTBCUFT-UHFFFAOYSA-N 0.000 description 1
- HJMCIHLESAJJQL-UHFFFAOYSA-N 3-phenylbutan-1-amine Chemical compound NCCC(C)C1=CC=CC=C1 HJMCIHLESAJJQL-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 238000005684 Liebig rearrangement reaction Methods 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
- TXOFSCODFRHERQ-UHFFFAOYSA-N N,N-Dimethylphenethylamine Chemical compound CN(C)CCC1=CC=CC=C1 TXOFSCODFRHERQ-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- HEFVRVOEBZDOJU-UHFFFAOYSA-N Vetrabutine Chemical compound C1=C(OC)C(OC)=CC=C1C(N(C)C)CCCC1=CC=CC=C1 HEFVRVOEBZDOJU-UHFFFAOYSA-N 0.000 description 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 150000001348 alkyl chlorides Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229940038926 butyl chloride Drugs 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- NDTCXABJQNJPCF-UHFFFAOYSA-N chlorocyclopentane Chemical class ClC1CCCC1 NDTCXABJQNJPCF-UHFFFAOYSA-N 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 150000008050 dialkyl sulfates Chemical class 0.000 description 1
- 229960004132 diethyl ether Drugs 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- HWJHWSBFPPPIPD-UHFFFAOYSA-N ethoxyethane;propan-2-one Chemical compound CC(C)=O.CCOCC HWJHWSBFPPPIPD-UHFFFAOYSA-N 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- UNFUYWDGSFDHCW-UHFFFAOYSA-N monochlorocyclohexane Chemical class ClC1CCCCC1 UNFUYWDGSFDHCW-UHFFFAOYSA-N 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N p-toluenesulfonic acid Substances CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229960003207 papaverine hydrochloride Drugs 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012956 testing procedure Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000003191 uterotonic effect Effects 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Definitions
- This' invention relates to novel tertiary amines having useful pharmacological properties and to their nontoxic acid addition salts and quarternary compounds.
- the present invention relates to tertiary amines having the general structural formulas R and R are alkyl with 1 to 6 carbon atoms, hydroxysubstituted alkyl'with 1 to 6 carbonatoms, cyclohexyl, phenyl, benzyl or, together with each other and the adjacent nitrogen atom, form a heterocyclic radical, such as 'piperidyl, morpholyl, or pyrrolidyl,
- R is alkyl with 1 to 4 carbon'atoms or alkoxy with l to 4 carbon atoms
- R is 2-alkoxywith 1 to 4 carbonatoms, 4-alkoxy with l to 4 carbon atoms or '4-hydroxyl,
- R is hydrogen, alkyl with 1 to 3 carbon atoms or alkoxy with 1 to 3 carbon atoms
- R is alkoxy with 1 to 4 carbon atoms and Z is alkylene with 1 to 4 carbon atoms,
- the tertiary amines having the above structural Formulas I and H may be prepared by reacting a-tertiary amino-"a-aryl-acetonitriles of the formulas Ha1-Mg-Z@ wherein Hal represents a halogen with an atomic weight from 35 to 127, inclusive, i.e. chlorine, bromine or iodine, and Z and R have the meanings previously defined.
- the reaction between compounds III or IV and compound V is advantageously carried out in the presence of a suitable organic solvent, such as diethylether, dibutylether, benzene, tetrahydrofuran, or dioxan, or a mixture of such solvents.
- the preferred method consists of refluxing the reaction mixture at the boiling point of the particular solvent medium, although the reaction will also proceed at moderately elevated temperatures below the boiling point of the solvent and without reflux.
- tertiary amines may be readily converted into their non-toxic acid addition salts or quaternary compounds by customary methods, as illustrated hereinafter.
- the free base was converted with ethereal hydrochloric acid into its hydrochloride having a melting point of 139 to 140 C.
- benzylchloride in 50 cc. of a 1:1 mixture of benzene and tetrahydrofuran. After adding thereto dropwise a solution of 24.4 gm. (4-rnethoxy-3-methyl-phenyl)-piperidyl-acetonitrile (boiling point is 145 to 146 C. at 0.1 mm.) in 50 cc. of a mixture of equal parts of benzene and tetrahydrofuran while continuously stirring, the mixture was heated for 1% hours at 60 to 70 C.
- EXAMPLE 10 1- (3,4-Dieth0xy-Phen0l) -1-Pyrrolidyl-2- l-Methyl- Phenyl) -Ethane-Phthalate 13.5 gm. 1-(3,4-diethoxy-phenyl)-1-pyrrolidyl 2 (4- methyl pheny1)-ethane, dissolved in 30 cc. isopropanol, were added to a solution of 6.3 gm. phthalic acid in about 30 cc. isopropanol, and the resulting mixture was heated to about 40 C. for a short time. After cooling, a small amount of ether was added and the mixture was placed into a refrigerator Where the resulting precipitate crystallized. Upon recrystallization from an ethanol-ether mixture, colorless crystals having a melting point of 112 C.
- EXAMPLE 12 1-(2,3-Dimethoxy-Phenyl)1-Dielhylamin0-4-Phenyl- Butane 24.8 gm. (2,3-dimethoxy-phenyl)-diethylamino-acetonitrile (melting point at 54 C.), dissolved in 50 cc. absolute ether, were added dropwise while stirring to a Grignard reagent prepared from 4.8 gm. magnesium powder and 39.8 gm. v-phenyl-propyl-bromide in 50 cc. absolute ether. On completion of the addition the reaction mixture was refluxed for two hours. The reaction mixture was then decomposed by adding cold water and dilute hydrochloric acid thereto until it was acid.
- EXAMPLE 13 1-(2-Eth0xy-Phenyl)-1 -Piperidyl-3-Phenyl-Propane 24.4 gm. (2 ethoxy phenyl) piperidyl acetonitrile (melting point at 78 C.) in 50 cc. of a mixture of benzene and tetrahydrofuran (1:1) were added dropwise to a Grignard reagent prepared from 4.8 gm. magnesium powder and 37 gm. ,B-phenyl-ethyl bromide in 50 cc. of a mixture of benzene and tetrahydrofuran (1:1). The reaction mixture was then heated for 1 /2 hours at C.
- EXAMPLE 14 1-(2,3-Dimeth0xy-Phenyl) -1-Diethylamino-3-Phenyl- Propane 24.8 gm. (2,3-dimethoxy-phenyl)-1-diethylamino-acetonitrile, dissolved in 50 cc. of a mixture of tetrahydrofuran and benzene (1:1), was added dropwise, while stirring, to a Grignard reagent prepared from 4.8 gm. magnesium powder and 37 gm. ,B-phenyl-ethyl bromide in 50 cc.
- EXAMPLE 15 The ether was evaporated from an ethereal solution of a Grignard reagent prepared from 4.8 gm. magnesium powder and 25.2 gm. benzyl chloride in 50 cc. absolute ether and replaced by the same quantity of absolute benzene. 27 .6 gm. (2-ethoxy-3-methoxy-phenyl)-morpholyl- 7 acetonitrile (boiling point at 155 C. at 0.4 mm. Hg), dissolved in 50 cc. absolute benzene, were then added dropwise and the resulting mixture was heated for about 1 hour at 70 C. The reaction mixture was then admixed propane, in 50 cc.
- the acetone was then distilled off, the oily residue was triturated several times with ether, and al- ⁇ 0 lowed to crystallize.
- the crystals were separated on a vacuum filter.
- the cr stalline uaternar salt had ameltand a bolhng point of 168 to 169 C. at 0.4 mm.
- Hg was q y mg point of 125 to 127 C.
- the yleld was 5.2 gm, which obtalned wlth a yield of of theory.
- methyl iodide were added to a solution of 6.4 used in their preparation, the reaction procedure and the gm. l-(2,3-dimethoxy-phenyl -1-diethylamino-3 -phenyl yield 1n each case.
- Example theory 34 1-(3,4-dimethoxy'- 173/015 (3,4-dimethoxy-phenybp-Bromo-anisole 1 95 phenyD-l-dimethyldimethylamino-acetoamino-2-(4-methoxynitrile. phenyD-ethane.
- V 90 1-(2-methoxy-phenyl)- 153/04 111 (2-methoxy-pheny1)- 'y-Phenyl-propyl 12 74 1-diethy1-amino-4- dretbylamino-acetobromide. phenyl-butane. nitrile.
- N 97 1-(2-n-propoxy-phenyD- 137/02 (2n -propoxy-p1 1enyl)- 6.-Brmo-propy1 12 66 1-dimethyl-arnino-3- dlmethyl-aminobenzene. phenyl-3-n1ethy1- acetonitnle. propane. 98 l-G-D-propoxy-phenyh- 153-154/03 119-120 do 'y-Phenyl-propyl 12 1 1-dlmethyl-arnlno-4 bromide. phenyl-butane.
- the tertiary amines of the present invention are in many cases Water-insoluble oils. It is, therefore, often convenient to use them pharmacologically and therapeutically as the more Water-soluble acid addition salts derived from non-toxic inorganic or organic acids or in the form of quaternary ammonium salts derived from alkyl, aralkyl or cycloalkyl halogenides, dialkyl sulfates or p-toluene sulfonic acid alkyl esters.
- Typical examples of pharmacologically useful nontoxic acid addition salts of the present tertiary amines are those formed With hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, nitric acid, acetic acid, propionic acid, butyric acid, valeric acid, oxalic acid, malonic acid, succinic acid, maleic acid, furnaric acid, lactic acid, tartaric acid, citric acid, malic acid, benzoic acid, phthalic acid, cinnamic acid, salicylic acid, nicotinic acid, -2-furoic acid and the like.
- the hydrochlorides have been found to be particularly suitable for practical purposes.
- Typical examples of pharmacologically useful, nontoxic quaternary compounds of the present tertiary amines are those formed With methyl iodide, methyl bromide, benzyl bromide, ethyl iodide, isobutyl bromide and other alkyl chlorides, bromides or iodides, dirnethyl sulfate, dietlryl sulfate, p-to luene sulfonic acid alkyl esters, cyclohexyl chlorides, bromides or iodides, cyclopentyl chlorides, bromides, or iodides, and the like, in accordance with customary quaternizing procedures such as those illustrated in the preceding examples.
- the group of compounds embraced by Formulas I and II above are useful and effective pharmocological agents. More particularly, they exhibit papaverine-like myotopic spasmolytic activities. In addition, certain compounds of 15 this group possess other desirable pharmacological properties in addition to being spasmolytics, such as hypo tensive, vasodilating and local anesthetic activities.
- Said compound was found to be 50% more effective than papaverine in releasing spasms of the rat uterus in situ which were caused by barium chloride.
- the dilating eflfect on the coronary blood-vessels was measured on dogs by means of the bubble-flow method described by Eckenhotf et al. in Am. J. Physiol., vol. 148, page 582 (1947). This effect as well as the blood pressure lowering effects in cats were also 25% greater than those of papaverine given in the same dose.
- l-(3.4-dimethoxy phenyl)-1-dimethylamino-4-phenyl butane hydrochloride is distinguished by a low toxicity. Its LD is 500 mg./kg. given perorally to rats and 320 mg./kg. on subcutaneous injection.
- the compound has the further advantage over papaverine and other spasmolytic agents of papaverine-like activity that it is readily water soluble and is locally well tolerated, also on parenteral administration to humans.
- the spasmolytic activity of l-(3,4-diethoxyphenyl)-1- diethylamino-4-phenyl-butane hydrochloride was tested in situ on the rat uterus, using the experimental arrangement of Engelhorn and Schmidt [Arzneistoffforschung, vol. 6 (1956), pages 454-457], and compared to the analogous spasmolytic activity of papaverine, a standard effective myotropic spasmolytic agent. It was found that the compound of the invention is 1.5 times more active as a spasmolytic than papaverine. Substantially the same spasmolytic activity was exhibited by the hydrochlorides of the following compounds:
- the following table shows additional comparative values of relative spasmolytic activity between various tertiary amine compounds according to the present invention and papaverine.
- the relative spasmolytic activity of papaverine hydrochloride was designated as being 1.0. These values were obtained by comparative tests on isolated guinea pig colons wherein spasms were induced with barium chloride. The testing procedure used to determine these values was that of Magnus (loc. cit.).
- Papaverine 1 (3,4 diethoxy phenyl)-1-dimethylamino-3 methyl-S-phenyl-propane 40
- l (4 ethoxy-3-methoxy-phenyl)-1-piperidyl- 3-methyl-3-phenyl-propane
- 50 (4 methoxy-3-ethoxy-phenyl)-1-dimethylamino-3-methyl-3-phenyl-propane
- 54 4 methoxy 3 ethoxy-phenyl)-1-diethylamino-3-methyl-3phenyl-propane 47
- 1-(2-n-propoxy-phenyl) 1 diethyla'mino-3- methyl-3-phenyl-propane hydrochloride was found to be spasmolytically 1.2 times more active than papaverine in an isolated guinea pig colon wherein spasms had been artificially induced with barium chloride.
- the compound was also twice as effective in dilating the arteria femoralis of anesthetized dogs than papaverine. Measurement of the coronary blood flow in dogs by the bubble-flow method also showed that this compound was 50% more effective than papaverine in its coronary dilating activity.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Description
United States Patent 3,133,967 1-(3,4-DIALKOXY-PHENOL)-1-DIALKYLAMlNO-3- AND-4-PHENYL BUTANES Ernst Seeger and August Kottl'er, Biberach an der Riss,
Germany, assignors to Boehringer Iugelheim G.m.b.H., Ingelheim (Rhine), Germany, a corporation of Germany No Drawing. Filed Feb. 4', 1960, Ser. No; 6,622 6 Claims. (Cl. 260570.5)
Thisi's a continuation-in-part of copending application Serial No. 710,186, filed January 21, 1958, now abandoned, which in turn is a continuation-in-part of application Serial No. 630,454, filed December 26, 1956, now abandoned, and Serial No. 691,549, filed October 22, 1957, now abandoned, said abandoned application Serial No; 630,454 being in turn a continuation-in-part of application Serial No. 544,385, filed September 21, 1955, now abandoned.
This' invention relates to novel tertiary amines having useful pharmacological properties and to their nontoxic acid addition salts and quarternary compounds.
More particularly, the present invention relates to tertiary amines having the general structural formulas R and R are alkyl with 1 to 6 carbon atoms, hydroxysubstituted alkyl'with 1 to 6 carbonatoms, cyclohexyl, phenyl, benzyl or, together with each other and the adjacent nitrogen atom, form a heterocyclic radical, such as 'piperidyl, morpholyl, or pyrrolidyl,
R is alkyl with 1 to 4 carbon'atoms or alkoxy with l to 4 carbon atoms,
R is 2-alkoxywith 1 to 4 carbonatoms, 4-alkoxy with l to 4 carbon atoms or '4-hydroxyl,
R is hydrogen, alkyl with 1 to 3 carbon atoms or alkoxy with 1 to 3 carbon atoms,
R, is alkoxy with 1 to 4 carbon atoms and Z is alkylene with 1 to 4 carbon atoms,
and their non-toxic, pharmacologically useful acid addition salts and quaternary compounds.
The tertiary amines having the above structural Formulas I and H may be prepared by reacting a-tertiary amino-"a-aryl-acetonitriles of the formulas Ha1-Mg-Z@ wherein Hal represents a halogen with an atomic weight from 35 to 127, inclusive, i.e. chlorine, bromine or iodine, and Z and R have the meanings previously defined. The reaction between compounds III or IV and compound V is advantageously carried out in the presence of a suitable organic solvent, such as diethylether, dibutylether, benzene, tetrahydrofuran, or dioxan, or a mixture of such solvents. The preferred method consists of refluxing the reaction mixture at the boiling point of the particular solvent medium, although the reaction will also proceed at moderately elevated temperatures below the boiling point of the solvent and without reflux.
The resulting tertiary amines may be readily converted into their non-toxic acid addition salts or quaternary compounds by customary methods, as illustrated hereinafter.
The following examples will illustrate the preparation of various representative compounds of the group defined by Formulas I and II above and will enable others skilled in the art to understand the present invention more completely. It will be understood, however, that the invention is not limited to the particular compounds illustrated in these examples.
EXAMPLE 1 1-(4-Hydr0xy-3-Methoxy-Phnyl) -1-M0rph0lyl- (4) -4-Phenyl-Butane A Grignard solution was prepared in the usual manner from 2.3 gm. magnesium turnings and 19.9 gm. phenylpi'opyl-bromide in 30 cc. anhydrous ether. The ether was evaporated and 60 cc. benzene were added in its place. Thereafter, a solution of 8 gm. (4-hydroxy-3-methoxyphenyl) morpholyl-(4)-acetonitrile were added dropwise and the resulting mixture was heated under reflux for 6 hours. The reaction mixture was then decomposed by nieans of ice and hydrochloric acid. The benzene layer was separated and discarded. Some ammonium chloride was added to the aqueous layer which was then made alkaline by adding ammonia. The oil precipitated thereby was dissolved in ether and the resulting" ethereal solution was dried over sodium sulfate. After evaporating the ether, 7 gm. of a compound having the structural formula OCH;
were obtained. On analysis, its nitrogen content was found'to be 4.7% (calculated: 4.1%). Its hydrochloride melted at 176 C.
EXAMPLE 2 1-(3,4-Dfmethoxy-Phenyl) 1-Dibutylamin0-4-Phenyl- Butane 4.6 gm. (3,4-dimethoxy-phenyl)-dibutylamino-acetonitrile were dissolved in 30 cc. absolute ether and the resulting solution was added dropwise to a Grignard solution prepared from 1.10 gm. magnesium and 9.0 gm. phenylpropyl-bromide in anhydrous ether. The resulting mixture was refluxed'for 3 hours, cooled, and'the reaction product was admixed with ice and 12% hydrochloric acid. The mixture separated into an ethereal and an aqueous phase. The ethereal phase was separated and discarded. Ammonium chloride and concentrated ammonia were added to the aqueous phase in an amount suflicient to make it alkaline. The oily substance precipitated thereby was extracted with ether, the ether extract solution was dried over sodium sulfate and the ether was evaporated. The residue was distilled in vacuo and yielded 4.5 gm. of an oily compound having the structural formula OCH OCH;
HoC4 \O4H9 and a boiling point of 210 C. at 0.4 m. Hg.
The free base was converted with ethereal hydrochloric acid into its hydrochloride having a melting point of 139 to 140 C.
EXAMPLE 3 I-(4-Meth0xy-3-Methyl-Phenyl) -1-Dimethylamin0- 3-Ph-enyl-Butane A Grignard reagent was prepared by adding 4.6 gm. magnesium powder to 39.8 gm. fi-phenyl-propyl bromide in absolute ether. After adding dropwise thereto a solution of 20.4 gm. (4-methoxy-3-methyl-phenyl)-dirnethylamino-acetonitrile (boiling point is 165 C. at 15 mm. Hg) in 50 cc. absolute ether while continuously stirring, the mixture was refluxed for two hours. Upon cooling by adding cold water, the reaction mixture was decomposed by adding dilute hydrochloric acid until it was acid. The ethereal layer which formed was separated and discarded while the aqueous hydrochloric layer was made alkaline with ammonia. The oil which separated out was taken up in ether, the resulting ether solution was dried over sodium sulfate and the ether was driven off. The oily residue was distilled in vacuo, yielding a yellowish oily compound having the structural formula 1-(4-Methoxy-3-Methyl-Phenyl) -I-Piperidyl- 2 -Phenyl-Ethane A Grignard reagent was prepared by adding 4.6 gm. magnesium powder to 25.2 gm. benzylchloride in 50 cc. of a 1:1 mixture of benzene and tetrahydrofuran. After adding thereto dropwise a solution of 24.4 gm. (4-rnethoxy-3-methyl-phenyl)-piperidyl-acetonitrile (boiling point is 145 to 146 C. at 0.1 mm.) in 50 cc. of a mixture of equal parts of benzene and tetrahydrofuran while continuously stirring, the mixture was heated for 1% hours at 60 to 70 C.
After cooling, water was added and then dilute hydrochloric acid until the mixture remained acid. The reaction mixture divided into an organic phase and an aque ous acid phase. The organic phase was separated and discarded, while the aqueous acid phase was made alkaline with ammonia. The oily precipitate formed thereby was taken up in benzene. A compound having the structural formula was obtained in the form of a yellowish oil having a boiling point of 170 to 171 C. at 0.5 mm. upon removal of the benzene by vacuum distillation. The yield was 71%. Its colorless hydrochloride, obtained by a precipitation with ethereal hydrochloric acid and recrystallization from acetone, melted at 180 to 181 C.
EXAMPLE 5 CH3 on and a boiling point of 179 to 180 C. at 0.2 mm. Hg was obtained with a yield of 75% of theory. Its hydrochloride, which was produced by precipitation with ethereal hydrochloric acid from acetone, was a colorless crystalline substance melting at C.
EXAMPLE 6 1- (3,4-Dieth0xy-Phenyl) -1-Dz'methylamino- Z-Phenyl-Ethane A Grignard solution prepared from 4.6 gm. magnesium powder and 25.2 gm. benzylchloride in absolute ether was reacted under the conditions described in Example 3 with a suspension of 24.8 gm. (3,4-diethoxy-phenyl)-dimethylamino-acetonitrile (melting point is 98 to 100 C.) in 250 cc. absolute ether. A yellowish oily compound having the structural formula OH; CH: and a boiling point of 158 C. at 0.2 mm. Hg was obtained With a yield of 70% of theory. After recrystallization from acetone, its colorles hydrochloride salt melted at 161 to 163 C.
EXAMPLE 7 1-(4-n-Butoxy-3-Methoxy-Phenyl) -1-Dz'methylamin0- 4-Phenyl-Butane A Grignard compound, prepared from 1.8 gm. magnesium shavings and 15 gm. 'y-phenyl-propyl-bromide in absolute ether was reacted under the conditions described in Example 3 with 13.1 gm. (4-n-butoxy-3-methoxyphenyl)-dimethylamino-acetonitrile (boiling point is C. at 0.3 mm. Hg) in ether. 9.5 gm. of a light yellowish oily compound having the structural formula and a boiling point of 199 C. at 0.5 mm. Hg were obtamed' EXAMPLE 8 1- (3,4-Dz'eth0xy-Phenyl) -1-Dimethylamino-4-Phenyl- Butane-Bromoethylate 2 gm. 1-(3,4-diethoXy-phenyl) 1 dimethylamino-4- phenyl-butane were heated for 2 hours under reflux in 40 cc. anhydrous acetone after addition of 3 gm. ethylbromide. Most of the acetone was then distilled off, and 75 cc. absolute ether were added. After standing for several hours in the cold, colorless crystals separated out which, after recrystallization from acetone, melted at 150 C. The yield was 1.9 gm.
EXAMPLE 9 1-(4-Eth0xy-3-Methoxy-Phenyl) -1-Dimethylamin0-4- Phenyl-Butane-Sulfate 16.4 gm. 1-(4-ethoxy-3-methoxy-phenyl)-'1-dimethylamino-4-phenyl-butane were dissolved in 50 cc. ether. While cooling and stirring, a mixture of 2.45 gm. concentrated sulfuric acid and 50 cc. ether were added to the solution. The salt which separated out solidified after standing in the cold. It was separated and recrystallized from an acetone-ether mixture, whereupon it took the form of colorless crystals having a melting point of 84 to 86 C. (decomp.).
EXAMPLE 10 1- (3,4-Dieth0xy-Phen0l) -1-Pyrrolidyl-2- l-Methyl- Phenyl) -Ethane-Phthalate 13.5 gm. 1-(3,4-diethoxy-phenyl)-1-pyrrolidyl 2 (4- methyl pheny1)-ethane, dissolved in 30 cc. isopropanol, were added to a solution of 6.3 gm. phthalic acid in about 30 cc. isopropanol, and the resulting mixture was heated to about 40 C. for a short time. After cooling, a small amount of ether was added and the mixture was placed into a refrigerator Where the resulting precipitate crystallized. Upon recrystallization from an ethanol-ether mixture, colorless crystals having a melting point of 112 C.
were obtained. EXAMPLE 11 1- (4-Ethoxy-3-Mthoxyphenyl) -1-Dimethylamin0-2- Phenyl-Ethane-Citrate 2 gm. citric acid, dissolved in isopropanol, were added to an isopropanol solution of 3 gm. 1-(4-ethoxy-3-methoxy-phenyl)-1-dimethylamino-2-phenyl-ethane. The mixture was heated for 1-0 minutes at 40 to 50 C. The precipitate which formed upon cooling was separated in the form of an amorphous mass which crystallized when triturated with ether. The yield was 3.5 gm.
EXAMPLE 12 1-(2,3-Dimethoxy-Phenyl)1-Dielhylamin0-4-Phenyl- Butane 24.8 gm. (2,3-dimethoxy-phenyl)-diethylamino-acetonitrile (melting point at 54 C.), dissolved in 50 cc. absolute ether, were added dropwise while stirring to a Grignard reagent prepared from 4.8 gm. magnesium powder and 39.8 gm. v-phenyl-propyl-bromide in 50 cc. absolute ether. On completion of the addition the reaction mixture was refluxed for two hours. The reaction mixture was then decomposed by adding cold water and dilute hydrochloric acid thereto until it was acid. The mixture divided into an etheral phase and an aqueous acid phase. The ethereal phase was separated and discarded and ammonia was added to the aqueous acid phase to make it alkaline. The oil which separated out was dissolved in ether, the resulting solution was dried over sodium sulfate and then the solvent was driven off. The residue was distilled in vacuo, yielding a yellowish oily compound having the structural formula 6 and a boiling point of 164 C. at 0.35 mm. Hg with a yield of 76% of theory. Its colorless hydrochloride was precipitated from ethereal hydrochloric acid and recrystallized from acetone, whereupon it melted at 133 to 134 C.
EXAMPLE 13 1-(2-Eth0xy-Phenyl)-1 -Piperidyl-3-Phenyl-Propane 24.4 gm. (2 ethoxy phenyl) piperidyl acetonitrile (melting point at 78 C.) in 50 cc. of a mixture of benzene and tetrahydrofuran (1:1) were added dropwise to a Grignard reagent prepared from 4.8 gm. magnesium powder and 37 gm. ,B-phenyl-ethyl bromide in 50 cc. of a mixture of benzene and tetrahydrofuran (1:1). The reaction mixture was then heated for 1 /2 hours at C. After cooling, water and dilute hydrochloric acid were added until the reaction mixture remained acid. The solution divided into an organic phase and an aqueous acid phase. The organic solvent phase was separated and the solvent distilled off. The residue was made alkaline with ammonia and the precipitate formed thereby was dissolved in benzene. The residue remaining after the evaporation of the benzene by distillation in vacuo was a yellowish compound having the structural formula and a boiling point of 159 to 161 C. at 0.3 mm. Hg. The yield was of theory.
Its colorless hydrochloride, obtained by precipitation from ethereal hydrochloric acid and recrystallization from acetone, melted at 122 to 123 C.
EXAMPLE 14 1-(2,3-Dimeth0xy-Phenyl) -1-Diethylamino-3-Phenyl- Propane 24.8 gm. (2,3-dimethoxy-phenyl)-1-diethylamino-acetonitrile, dissolved in 50 cc. of a mixture of tetrahydrofuran and benzene (1:1), was added dropwise, while stirring, to a Grignard reagent prepared from 4.8 gm. magnesium powder and 37 gm. ,B-phenyl-ethyl bromide in 50 cc. of a mixture of tetrahydrofuran and benzene (1:1), and the resulting reaction mixture washeated for 1.5 hours at 70 C. The reaction mixture was then admixed with water and dilute hydrochloric acid, whereby it divided into an organic phase and an aqueous acid phase. The organic solvent phase was separated and discarded and the aqueous hydrochloric acid phase was made alkaline with ammonia. The oil which separated was dissolved in benzene. The residue remaining after evaporation of the benzene by distillation in vacuo yielded a yellowish oily compound having the structural formula and a boiling point of 148 C. at 0.08 mm. Hg. The yield was 37% of theory.
Its colorless hydrochloride, recrystallized from acetone, melted at 156 C.
EXAMPLE 15 The ether was evaporated from an ethereal solution of a Grignard reagent prepared from 4.8 gm. magnesium powder and 25.2 gm. benzyl chloride in 50 cc. absolute ether and replaced by the same quantity of absolute benzene. 27 .6 gm. (2-ethoxy-3-methoxy-phenyl)-morpholyl- 7 acetonitrile (boiling point at 155 C. at 0.4 mm. Hg), dissolved in 50 cc. absolute benzene, were then added dropwise and the resulting mixture was heated for about 1 hour at 70 C. The reaction mixture was then admixed propane, in 50 cc. of absolute acetone, and the resulting mixture was heated under reflux for 4 hours on a water bath. The acetone was then evaporated and the oily residue was triturated with ether. Crystallization set in after with water and dilute hydrochloric acid, whereby it 5 a short time. The crystalline product was separated on divided into an organic phase and an aqueous acid phase. a vacuum filter and recrystallized from acetone. The The organic solvent phase was separated and discarded quaternary salt had a melting point of 158 C. The yield and the aqueous hydrochloric acid phase was dissolved was 7 gm., which is 76% of theory. 1n benzene, the benzene was evaporated and the residue EXAMPLE 17 was d1st1lled 1n vacuo. A yellowish oily compound hav- 10 I I i th structural f l 1-(2Meth0xy-Phenyl) -1-Dlmethylammo-3-Phenyl- Propane Benzylobromide OH 0 00 11 5.2 gm. 1 (2 methoxy-phenyl)-1-d1methylam1no-3- phenyl-propane were dissolved in 50 cc. absolute acetone, 1 15 4 gm. benzyl bromide were added to the solution and the mixture was heated under reflux for about 4 hours on a water bath. The acetone was then distilled off, the oily residue was triturated several times with ether, and al- \0 lowed to crystallize. The crystals were separated on a vacuum filter. The cr stalline uaternar salt had ameltand a bolhng point of 168 to 169 C. at 0.4 mm. Hg was q y mg point of 125 to 127 C. The yleld was 5.2 gm, which obtalned wlth a yield of of theory. Its hydrochlois 65% of theory recrystaulzed from acetons melted at 155 to 156 The following table 1llustrates addltlonal tertiary amines EXAMPLE 16 having the structural Formulas I and II above which 25 were roduc d n 1-(2,3-Dlmeth0xy-Phenyl)-1-DzethyIamzn0-3-Phenylp a d.hsts the bolhng l the free Pro an e Meth dl-de base, the melting po1nt of the corresponding hydrochlo- P ride addition salt, the acetonitrile and Grignard reagents 3 gm. methyl iodide were added to a solution of 6.4 used in their preparation, the reaction procedure and the gm. l-(2,3-dimethoxy-phenyl -1-diethylamino-3 -phenyl yield 1n each case.
Reaction Yield Example Tertiary amine B.P., M.P. of Grignard reagent procedure percent N 0. produced M.P., C. C./mm. Hg hydrochlo- Acetonitrile reagent from magnesium and as in of ride, 0. Example tlzeory 18 1-(3A-dimethoxy- 215/66 (3,4-dimethoxy-phen yl)- 'y-Pheuyl-propyl-bro- 2 31 phenyD-l-pyrrolidylpyrrohdyl-acetonrile. mide. 4-phenyl-butane. 19 1-(4-hydroxy-3-methoxy- 106 (recrys- 14 (4-hydr0xy-6-mcthoxydo 2 phenyDd-dimethyltallized phenyD-dlmethylaminol-phenylfrom amino-aeetonitrile. butane. CH3OH). 20 1-(4-hydr0xy-3meth0xy- .-...d0 p-Xylyl-bromide 2 48 phenyD-l-dimethylamino-2-(4-methylphenyl)-ethane. 21 1-(4-hydr0xy-3-methoxy- 160 (4-hydr xy-3-methoxyy-Phenyl-propyl-brophenyl)-1-pyrrolidylphenyl )-pyrrol1dyl- Inide. 4-phenyl-butane. acetonltrlle. 22 1-(4-l1ydroxy-3-rnethoXy 141 (recrys- 165 (4-hydr0xy-3-methoxy- Benzylehloride 2 phenyD-l-piperidyl-2- tallized phyenyD-pipendylphenyl ethane. from acetonitrile.
CzHaOH). 23 l-(4-hydroxy-3-methoxy- 111(reerys- 186 ..d0 fl-Phenyl-ethyl bromide- 2 60 p%enyl)-1-piperidyl-3- tallized GD [0132116. m p y p CzHaOH) 24 1-(4-hydroxy-3-methoxy- 4 ..d0 'y-Phenyl-propyl-bro- 2 50 phenyD-l-piperidyl-4- mide. phcnyl-butane. 25 1-(4-l1ydroxy-3-methoxy- 113-114 .410 A-Pheuyl-butyl-chloride. 2 46 phenyD-Lpiperidyl-5- (recrysphenyl-pentane. tallized from CzH OH). 26 l-(BA-dimethoxy- 166168/0.1 138-139.-.. (3,4-dimethoxy-pheny1)- 'y-Phenyl-propyl-bro. 2 35 phenyD-l-dimethyldimethylamino-aeetomide. amino4-phcnyl-bunltrlle. tune. 27 1-(3,4-dimethoxy- 156/63 213 d0 B-Bromo-isopropyl- 2 52 phenyD-l-dimethylbenzene. amino-3-metl1yl-3- phenyl-propane. 28 I-(BA-dimethOxy- 200/0-1 158 (3,4 -dnnethoxy-phen yl)- 'y-Phenyl-p opyl-bro. 2 (36 pl1enyl)-1-piperidy1- piperidyl-aeetonitrile. mide. 4-pl1enyl-butane. 29 1-(4hydroxy-3-InethoXy- (tritnr- (4-hydroxy-3-meth0x3 Benzyl-chloride 2 65 phenyD-l-dimethylated with phenyl)-d1methylamino-Z-phenylpetroleum amino-aceonitrile. ethane. ether). 30 1-(4-hydroxy-3-methoxy- 78 (recrys- 175 (4-hydr0xy-3-meth0xyp-Xylyl-bromide 2 67 phenyD-l-piperldyltallized phenyD-prpendyl- 2-(4-methyl-phenyhfrom acetonitnle. ethane. OHsO 31 1-(3,4-dimethoxy- 151/0.1 192 (3,4;d1meth0Xy-phenyD- Benzylcholride 1 73 phenyD-l-dimethyldrrnethylammo-acetoamin0-2-phenylnitrlle. ethane. 32 1-(3,4'di1neth0xy- 65/11 d0 B-Phenylethylbromide 1 61 phenyl)-1-dimethylamino-B-phenyl- DIODEHIB. 33 1-(3,4-dimetl10xy- /62 213(recrysdo fl-Bromo-iso-propyl- 1 70 phenyD-l-dimethyltalhzed bromide. amino-3-methylfrom S-phenyl-propane. ethanol ether).
Reaction Yield Example Tertiary amine B.P., M.P. of Grignard reagent procedure percent No. produced M.P., C. O./mm. Hg hydrochlo- Acetonitrile reagent from magnesium and asin of ride,O. Example theory 34 1-(3,4-dimethoxy'- 173/015 (3,4-dimethoxy-phenybp-Bromo-anisole 1 95 phenyD-l-dimethyldimethylamino-acetoamino-2-(4-methoxynitrile. phenyD-ethane. 35 1-(3,4-dimethoxy- 168/005 138 (3,4-dimethoxy- 'y-Phenyl-propyl-bro- 1 66 phenyD-l-diethylpheny1)-diethylmide. gmino-i-phenylamino-acetonitrile.
utane. 36 l-(3,-methy1-4-methoxy- 143/62 170 (3-methy1-4-methoxyfl-Phenyl-ethylbromide, 3 74 phenyl)-1-dimethy1- phenyD-dimethylamino-3-phenylamino-acetonitrile.
propane. V 37 1-(3-ethoxy-4-methoxy- 153-154/0.35 (3-ethoxy-4-methoxyfl-Bromo-propyl- 3 83 phenyD-l-dimethylphenylhiimethylbenzene. amino-3-methy1-3- amino-acetonitrile. phenyl-propane. 38 l-(3,4-diethoxy- 176/04 135-136.... (SA-diethoxy-phenybv-Phenyl-propyl-bro- 5 41 phenyD-l-diethyldiethylamino-acetomide. amino-4-pheny1- nitrile. butane. 39 1-(3-methoxy-4-ethoxy- 183/03 154-155.... (3-methoxy-4ethoxy- ...-d 57 phenyD-l-pyrrolidylphenyD-pyrrohdyl- 4-pheny1-butane. aeetonitrile. 4O 1-(3,4-diethoxy- 165/025 (3,4-diethoxy-phenybfl-Bromo-propyl- 3 72 phenyD-l-diethyldiethylamino-acetobenzene. amino-3-methy1-3- nitrile. phenyl-propane. 41 1-(3-1nethoxy-4-ehory- 183/045 150-151.... (3-methoxy-4-ethoxya-Pheny1-propy1- 5 5 phenyl) -1-diethy1apheny1)- diethylabromide mine-4-pheny1- mino-acetonitrile. butane. 7 42 1-(3,4-diethoxy-pheny1)- 167/025 185-186-.-. (3,4d1eth0xypheny1)- Xylyl bromide 5 5 l-pyrrolidyl-Z-p-tolylpyrrolidyl-acetoni- I name. trile. 43 l-(3,4-dieth0xy-pheny1)- 195/025 152-153.... 3,4-diethoxypheny1)- 'y-Phenyl-propyl- 3 32 1-piperidy1-4-pheny1- piperidyi-acetonibromide. butane. trile. 44 1-(3-ethoxy-4-meth0xy- 182/05 126 (B-ethoxy-i-methoxydo 3 0 pheny1)-1-dimethylphenyD-dimethylgmino-i-phenylamino-acetonitrile. utane. 45--.- 1-(3,4-diethoxy-pheny1)- 17110.3 136 (3,4-diethoxypheny1)- fl-Phenylethylbromideu 5 2 1-diethy1amino-3- 4 diethylamino-aeetoniphenylpropane. tri 6.--. 1-(3-ethoxy-4-methoxy- 181/045 139 (3-ethoxy-4-n1eth0xy- 'y-Phenyl-propyl- 3 70 pheny1)-1-diethy1- phenyD-drethylammobromide. amino-4-pheny1- acetonitriie. butane. 47 1-(3-eth0xy-4-methoxy- 164/035 ..do B-Phenyl-propyl- 5 70 phenyD-l-diethylbromide. amino-3-methy1-3- phenyl-propane. 4s 1-(3-lI1ethyl-4-methoxy- 137/01 187 (3-methy1-1-methoxy- Benzylbromide 3 3 phenyl)-1dimethy1- phenyD-dimethylamino-Z-phenyiamino-acetonitrile. ethane. 49 1-(3-methy1-4-methoxy- 151/02 185-186.... -do 'y-Phenyl-plopyl- 3 6 phenyD-l-dimethylbromide. amino-i-phenylbutane. V 50 1-(3-111ethy1-4-methoxy- 169/045 148-149.... (3-methy1-4-methoxydo 3 68 pheny1)-1-diethy1- phenyD-diethylaminoamino-4-pheny1- acetonitrile. butane. 51 l-(3-methy1-4-1nethoxy- 142/0. 04 203 (3-methy1-4-methoxy- Benzyi bromide 3 1 phenyl) -1-pyrr01idylphenyi) -pyrro11dyl- 2-phenyl-ethane. aeetonitrile. 52 l-(3- 1eth0xy-4-ethoxy- 153/03 174-176..-. (3-methoxyA-ethoxy- ....do 5 5 phenyD-l-dimethylphenyl)-dimethylamino-Z-phenylamino-acetonitrile. ethane. 53 l-(3-methoxy-4-ethoxy- 154-155/025 .do fi-Phenyl-propyl- 5 77 phenyD-l-dimethylbromide. amino-3-methy1-3- phenyl-propane. V 54 1(3-methoxy-4-ethoxy-- 171/0.4 (3-methoxy-4-ethoxy- .do 3 75 pheny1)-1-diethy1- phenyD-diethylamino-3-methyl-3- amino-acetonitrile. phenyl-propane. I 55 1-(8-methoxy-4-ethoxy- 205-206/0.3 (3-methoxy-1-ethoxy- 'y-Phenyl-propyl- 5 77 phenyD-l-piperidyl-4- pheny1)-piperidy1- bromide. phenyl-butane. acetonitrile. 56 1-(3methoxy4-ethoxy- 185/03 .-do B-Phenyl-propyl- 5 71 pheny 1)-1-piperidy1-3- bromide. methyl-3-pheny-lpropane. 57..... 1-(3,4-diethoxy-pheny1)- 153/006 128-129.--- (3,4-diethoxy-phenyl)- -phenyl-propyl 5 0 1-dimethy1-amino+ dimethylamino-aeetobromide. phenyl-butane. nitrile. 58 1-(3,4-diethoxy-phenyl)- 160/03 ..do fl-Phenyl-propylbro- 5 78 1-dimethyl-an1ino-3- mide. methy1-3pheny1- propane. 59 1-(3,4-diethoxy-pheny1)- 167/025 (3,4-diethoxy-phenyD- Xylyl bromide 5 65 1-pyrro1idy1-2-p-to1y1- pyrrolidyl-acetoethane. nitrile. 1-(3-methoxy-4-n-pro- 168/03 (Ii-methoxy-i-n-propyl- B-Phenyl-ethyl-bromide. 3 55 poxy-phenyD-l-diphenyl)-dimethyl-' methylaminoiamino-acetonitrile. phenyl-propane. 61. 1-(3,-methoxy-4-is0pr0- 163/03 (3-methoxy-4-isopro- Benzyl bromide 3 3 p y-p e yb- -ny p y-p y )-py 1dyl-2-phenyl-ethane. rolidyl-aeetonitrile.
Reaction Yield Example Tertiary amme B.P., M.P. of 4 Grignard reagent procedure percent No. produced M.P.,C. O./mm.Hg hydrochlo- Aeetonltrile reagent from magnesium and as in of r1de,-C. Example theory 62 1-(2,3-diethoxy-phenyl)- 145/03 (2,3-diethoxy-phenyl)- B-Phenyl-propyl bro- 12 75 1-dimethy1amino-3- dimethyl-aminomide. pheny1-3-methylacetonitrile. propane. 63 1(2,3-diethoxy-phenyl)- 165/0.4 d 'y-Phenyl-propyl-bro- 12 61 1-dimcthylamino-4- mide. phenyl-butane. 64 1-(2,3-di1nethoxy phen- 142/02 (2,3-dimethoxy-phenyD- fl-Phenyl-propyl 12 52 yl)-1-dimethyl-aminodirnethyl-aminobromide 3-methyl-3-phenylacetonitrile. propane. 1-(2,3-din1ethoxy- 145/007 do. 'y-Phenyl-propyl 12 65 phenyD-l-dimethylbromide. amino-4-phenylutane. G6 1-(2,3-dimethoxy- 146/04 200-201.-.. (2,3-dimethoxy-pheny1)- Benzyl bromide 12 82 phenyD-l-diethyldiethyl-aminoamino-2-pheny1- aoetonitrile. ethane. 67 1-(2,3-dimethoxy- 144/025 170-171---- do fi-Phenyl-propy1 12 76 phenyl)-1-diethylbromide. amino-3-rnethyl-3- phenyl-propane. 6s 1-(2,3-dimethyoxy- 159160/0.03 117-118.-.. (2,3-dimethoxy-pheny1)- BPhenylethyl 13 60 phenyD-l-pyrrolidylpyrrolidylbromide. 3-phenyl-propane. acetonitrile. 69 1-(2,3-dimethoxy- 169/04 do fl-Phenybpropyl 12 67 pheny1)-1-pyrro1idylbromide. 3-Inethyl-3-phenylpropane. 70 1-(2,3-dimethoxy 161/01 151- .do. 'y-Phenyl-propyl- 12 71 phenyl)-1-pyrro1idy1- bromide. 4-pheny1-butane. 71 1-(2,3-dimethoxy- 173/03 ,3-di ethoxy-phenyD- fl-Phenyl-propyl 12 66 pheny1)-1-piperidylp p idylde- 3-methyl-3-pheny1- ecetonitrile. propane. 72 l-(2,3-dimethoxy- 176/025 157-158.... .....(10 'y-Phenyl-propyl 12 74 phenyl)-1-piperidylbromide. 4-phenyl-butane. 73 l-(2+sthoxy-3-methoxy- 152/05 147-148...- (2-ethoxy-3-methoxy- Benzyl bromide 12 84 phenyD-l-dimethylpheny1)-dimethylamino-Z-phenylamino-acetonitriie. ethane. 74 1-(2-ethoxy-3-methoxy- 141-142/0. 17 d0 flphenyl-propyl 12 33 phenyD-l-dimethylbromide. amino-3-methyl-3- phenyl-propane. 75 1-(2-eth0xy-3-methoxy- 172/02 d0 'y-Phenyl-propyl 12 67 phenyD-l-dimethylbromide. amin0-4-pheny1- butane. 76 l-(2-ethoxy-3methoxy- /025 202 (2ethoxy-3I nethoxy- Benzyl bromide 12 81 phenyl)-1diethylp yD-dmhyb amino-Z-phenylamino-acetonitrile. ethane. 77 l-(2-ethoxy4i-methoxy- 141/01 2 Xylyl bromide 12 7 phenyD-l-diethylamino-2-p-tolyI-ethane. 78 1-(2-ethoxy-3-methoxy- 152/035 -do B-Pbenyl-propylbro- 12 76 phenyD-l-diethylalde. mino-3-methy1-3- phenyl-propane. 79 1-(2ethoxy-3-methoxy- /035 146 (2-ethoxy-3-methoxy- Benzyl bromide 12 63 phenyl)-1-pyrrolidylpheny1 )-pyrro1idyl- 2-phenyl-ethane. aeetonitrile. 80 1-(2-ethoxy-3-methoxy- /035 (2-ethoxy-3-methoxy- 'y-Phenyl-propyl 12 76 phenyl)-1-diethylphenyD-diethylbromide. amino-i-phenylamino-aeetonitrile. butane. 81 1-(2-ethoxy-3-metl1oxy- /035 (2-ethoxy-3-methoxy- B-PhenyLpropyl 12 3 phenyD-l-pyrrolidyiphenyD-pyrrohdylbromide. 3-methyl-3-phenylacetonitrlle. propane. 82 1-(2-ethoxy-3-methoxy- 171/025 123 .d0 'y-Phenyl-propyl 12 70 phenyD-l-pyrrolidylbromide. 4-phenyl-butane. 83 1-(2-eth0Xy-3-methoxy- 174/03 (2-ethoxy-3-n1ethoxyfi-PbenyI-propyl 12 03 phenyD-l-piperidylphenyD-prperidylbromide. S-methyl-S-phenylacetonitrile. propane. 84 1-(2ethoxy-3-methoxy- IOU/0.35 146 do 'y-Phenyl-propyl 12 65 phenyl)-1-piperidy1- bromide. 4-phenyi-butane. 85 1-(2-methoxy-phenyD- 117/01 162 (2-methoxy-phenyD- Benzyl bromide 12 70 l-dimethylamino-Z- dimethylaminophenybethane. acetonitrile. 86 1-(2-meth0xy-phenyD- 138/045 117-118.. .d0 fl-Phenyl-ethyl bromide- 12 80 1-dimethy1amino-3- phenyl-propane. 87 1-(2-methoxy-phenyD- 123/015 do fl-Bromo-propyl- 12 71 1-dimethyl-amino-3- benzene. methy1-3-pheny1- propane. 88 1-(2-methoxy-phenyD- 146147/O.5 (2-methoxy-phenyD- do 12 71 1-diethy1-amino-3- diethyl-acetonitrile. methyl-3-phenylpropane. 39 1-(2-methoxy-phenyD- 144/0. 45 129-130.... (Z-methoxy-phenyD- Benzy1bromide 12 75 pyrrolidyl-Z-phenylpyrrohdyl-acetoethane. nitrile. V 90 1-(2-methoxy-phenyl)- 153/04 111 (2-methoxy-pheny1)- 'y-Phenyl-propyl 12 74 1-diethy1-amino-4- dretbylamino-acetobromide. phenyl-butane. nitrile.
Reaction Yield Example Tertiary amine B.P., M.P. of Grignard reagent procedure percent No. produced M.P., O. C./mm. Hg hydrochlo- Acetonitrile reagent from magnesium andas in ride, 0. Example theory 91 l-(2-methoxy-phenyD-1- 158/04 134-135 (2-methoxy-phenyl)- Xylylbromlde 12 73 piperidyl-2-p-tolyl- (depiperidyl acetoethane. comp). nltrlle. 92 1-(2-ethoxy-phenyl)-1- 115/111 129430.... (2-ethoxy-phenyD- Benzyl bromlde 12 64 dimethylamino-2- dimethylaminophenyl-ethane. acetonitrile. 93 1-(2-ethoxy-phenyD-1- 140/05 do fl-Bromo-propyl 12 66 dimethylamino-3- benzene. methyl-3-phe11ylpropane. 94 thOXy-ph HyD-I- 145/0.35 120421---- do 'y-Phenyl-propyl 12 e4 dlrnethylaminolbromide. phenyl-butane. 95 1-(2-ethoxy-phenyD-1- 135/02 (2-ethoxy-phenyl)- fi-Brorno propyl 12 84 diethylamino-S- diethylammobenzene. methyl-3-phenylacetonitrile. propane. 96 1-(2-ethoxy-phenyD-1- 145/04 153-154 (2-ethoxy-phenyD- Benzyl bromide. 12 70 pyrrolidyl-2-phenylpyrrohdyl-acetohane. nitrile. N 97 1-(2-n-propoxy-phenyD- 137/02 (2n -propoxy-p1 1enyl)- 6.-Brmo-propy1 12 66 1-dimethyl-arnino-3- dlmethyl-aminobenzene. phenyl-3-n1ethy1- acetonitnle. propane. 98 l-G-D-propoxy-phenyh- 153-154/03 119-120 do 'y-Phenyl-propyl 12 1 1-dlmethyl-arnlno-4 bromide. phenyl-butane. 99 I-(Z-mpropoxy-phenyh- 172-173/0.3 (2-n .-propoxy-phenyl)- p-(Methoxy-phenyD- 1-diethy1-amino2-pdiethyl-arninomethyl bromide. Ilggthoxy-phenylaeetomtrlle. e ane. 100 1-(2-n-propoxy-phenyl)- /02 108-109 (2-n-propoxy-phenyl)- B-PhenyLethylbromme. 12 76 l-pyrrolidyl-3- pyrrolldyl-acetophenyl-propane. nitrile. 1 101 I-(Z-D-propoxy-phenyD- /0. 45 150-157 (2-n-propoxy-phenyl)- Benzylbrom1de. 12 67 1-piperidyl-2-phenylpiperldyl-acetoethane. nitr le. 102 1-(2,3-dimethoxy- 155/015 113-114 (2,3 -dimetho xy-phenyl)- -Phenyl-propyl 12 57 pheny1)-1-diethy1- d1ethylammobromide. amino-4-phenylacetonitrile. butane. 103 1-(2-ethoxy-phenyl)- 157/02 (2-e thoxy-ph enyl)-- --d0 12 74 1diethylan1ino-4- diethylaminophenyl-butane. acetonitrile. 104 1-(2 th0xy-phenyD- 175/01 108-110-.-. (2-ethoxy-phe11yl)- do 12 o 1-pyrrolidyl-4- pyrrohdyl-aeetophenyl-butane. nitrile. 105 1-(2-ethoxy-phenyD- 155/0.15 "do fi-Phenyl-pr0py1 12 78 1-pyrrolidy1-3-methylbromide. S-phenyl-propaue. 106 l-(2rethoxy-phenyb- 178-179/0. 15 134 (2e thoxy-pheny1)- -Phenyl-propyl 12 79 1-plperidyl4-phenylpiperidylaeetobromide. butane. nltrile. 107 l-(2-ethoxy-pheny1)- 169/0.07 .do fi-Phenyl-propyl 12 79 1-piperidyl-3-methylbrom1de. S-phenyl-propane. 108 l-(2rn-propoxy-phenyn- 104/04 (2-n-propoxy-phenyD- -Phenyl-propyl 12 e4 1-dietl1yl-amino-4- diethyl-amiuobromide. phenyl-butane. acetonitrile. 109 I-(Z-n-propoxy-phenyb- 152/0.4 d0 B-Phenyl-propyl 12 82 l-diethyl-amino-Zibromide. methy1-3-phenylpropane. 110 1-(2-n-pr p0xy'phenyD- 174/02 110-111---- (z-n-propoxy-phenyb- -Phenyl-propyl 12 e9 l-pyrrolidyll phenylpyrrol1dylbromide. butane. acetonitrile. 111 l-(2-n-propoxy-phenyD- 172-175/0.3 do fl-Phenyl-propyl 12 80 l-pyrrolidyl-3- bromide. methy1-3-phenylpropane. 112 1-(211-propoxy-phenyD- 17617s/0.25 (2n-propoxy-phenyl) 'y-Phenyl-propyl 12 69 l-piperidyll-phenyl piperidyl-acetonitrile. bromide.
utane. 113 1-(2-n-propoxy-phenyl)- /025 do fl-Phenyl-propyl 12 64 l-piperidyl-B- bromide. methy1'3-pheny1- propane.
As previously stated and illustrated in the preceding examples, the tertiary amines of the present invention are in many cases Water-insoluble oils. It is, therefore, often convenient to use them pharmacologically and therapeutically as the more Water-soluble acid addition salts derived from non-toxic inorganic or organic acids or in the form of quaternary ammonium salts derived from alkyl, aralkyl or cycloalkyl halogenides, dialkyl sulfates or p-toluene sulfonic acid alkyl esters.
Typical examples of pharmacologically useful nontoxic acid addition salts of the present tertiary amines are those formed With hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, nitric acid, acetic acid, propionic acid, butyric acid, valeric acid, oxalic acid, malonic acid, succinic acid, maleic acid, furnaric acid, lactic acid, tartaric acid, citric acid, malic acid, benzoic acid, phthalic acid, cinnamic acid, salicylic acid, nicotinic acid, -2-furoic acid and the like. The hydrochlorides, however, have been found to be particularly suitable for practical purposes.
Typical examples of pharmacologically useful, nontoxic quaternary compounds of the present tertiary amines are those formed With methyl iodide, methyl bromide, benzyl bromide, ethyl iodide, isobutyl bromide and other alkyl chlorides, bromides or iodides, dirnethyl sulfate, dietlryl sulfate, p-to luene sulfonic acid alkyl esters, cyclohexyl chlorides, bromides or iodides, cyclopentyl chlorides, bromides, or iodides, and the like, in accordance with customary quaternizing procedures such as those illustrated in the preceding examples.
The group of compounds embraced by Formulas I and II above are useful and effective pharmocological agents. More particularly, they exhibit papaverine-like myotopic spasmolytic activities. In addition, certain compounds of 15 this group possess other desirable pharmacological properties in addition to being spasmolytics, such as hypo tensive, vasodilating and local anesthetic activities.
These pharmacological properties of the compounds according to the present invention are quite unlike those of related primary and secondary amines, and even diametrically opposed to those of related tertiary amines. Thus, it is known that primary diphenyl-ethylamines wherein one of the phenyl radicals is di-substituted exhibit primarily analgesic properties, as do secondary diphenyl-ethylamines. It is therefore a surprising and unexpected discovery that related tertiary amines exhibit primarily myotropic spasmolytic properties. Moreover, it is known that tertiary amines with a terminal amino group exhibit uterotonic properties, whereas some of the compounds of the present invention exhibit exactly the opposite properties, namely a specific utero-spasmolytic effect.
To demonstrate the surprisingly effective and versatile pharmacological properties of the tertiary amines according to the present invention the following tests were made: 1 (3,4 dimethoxy phenyl)-1-dimethylamino-4- phenyl butane hydrochloride showed in a dose of 5 mg./kg. intravenously administered to rabbits a spasmolytic activity which corresponds to but lasted about twice as long as that of papaverine administered in the same dose and manner. This test was carried out by flowing an 0.01% solution of barium chloride through the abdominal cavity of a living rabbit as described by Brock et al. in Arch. Exp. Path & Pharrn., vol. 215, page 492 (1952) and recording the movement of the intestines according to the method of W. Straub.
Said compound was found to be 50% more effective than papaverine in releasing spasms of the rat uterus in situ which were caused by barium chloride. The dilating eflfect on the coronary blood-vessels was measured on dogs by means of the bubble-flow method described by Eckenhotf et al. in Am. J. Physiol., vol. 148, page 582 (1947). This effect as well as the blood pressure lowering effects in cats were also 25% greater than those of papaverine given in the same dose.
Furthermore, l-(3.4-dimethoxy phenyl)-1-dimethylamino-4-phenyl butane hydrochloride is distinguished by a low toxicity. Its LD is 500 mg./kg. given perorally to rats and 320 mg./kg. on subcutaneous injection.
The compound has the further advantage over papaverine and other spasmolytic agents of papaverine-like activity that it is readily water soluble and is locally well tolerated, also on parenteral administration to humans.
1 (3,4-dimethoxy-phenyl)-l-dimethylamino-4-phenylbutane hydrochloride has also been used clinically as uterine spasmolytic agent for some years. It effects a considerable accleration of birth without side effects being observed until now. Above all the circulatory system is not affected.
The spasmolytic activity of l-(3,4-diethoxyphenyl)-1- diethylamino-4-phenyl-butane hydrochloride was tested in situ on the rat uterus, using the experimental arrangement of Engelhorn and Schmidt [Arzneimittelforschung, vol. 6 (1956), pages 454-457], and compared to the analogous spasmolytic activity of papaverine, a standard effective myotropic spasmolytic agent. It was found that the compound of the invention is 1.5 times more active as a spasmolytic than papaverine. Substantially the same spasmolytic activity was exhibited by the hydrochlorides of the following compounds:
1-(3,4-diethoxy-phenyl)-1-dimethylamino-4-phenylbutane 1- (4-ethoxy-3-meth0xy-phenyl l-dimethylamino-3- methyl-3-phenyl-propane 1-(4-ethoxy-3-methoxy-phenyl)-1-diethylamino-4- phenyl-butane 1-(4-methoxy-3-methy1-phenyl)-1-dimethylamino-3- phenyl-propane 1 6 1- (4-methoxy-3-ethoxy-phenyl) -1-dimethylamino-3- methyl-3-phenyl-propane 1-(4-methoxy-3-ethoxy-phenyl) -1-diethylamino-4- phenyl-butane 1- (4-methoxy-3-ethoxy-phenyl l-diethylamino-3- methyl-S-phenyl-propane.
In another comparative test, using the experimental arrangement of Magnus [Pfiugers Archiv, vol. 102 (1904), page 123], the spasmolytic activity of 1-(4- methoxy 3 methyl-phenyl)-1-dimethylamino-3-methyl- 3-phenyl-propane hydrochloride was found to be twice as great than papaverine in suppressing spasms of the isolated guinea pig colon induced with barium chloride. In tests on cats it was also found that this compound was twice as effective as papaverine in lowering the blood pressure; i.e. when administered in equal doses 1-(4- methoxy 3 methyl-phenyl)-1-dimethylamino-3-methyl- 3-phenyl-propane hydrochloride lowered the blood pressure twice as much as papaverine. Similarly, using the experimental arrangement of Bornstein [Naunyn- Schmiedebergs Archiv, vol. (1926), page 367], it was found in tests on cats that the vasodilating effect of the compound was five times greater than that of papaverine when administered in equal doses.
Using the method of Magnus (loc. cit.), it was also determined that 1-(4-ethoxy-3-methoxy-phenyl)-l-dimethylamino-4-phenyl-butane hydrochloride is 1.5 times more active as a spasmolytic than papaverine, as determined on the isolated guinea pig colon. The vasodilating activity of the compound was found to be substantially equal to that of papaverine, as determined on an isolated rabbit ear by the method of Krawkow and Pissemski (Then, Pharmakol. Methoden, page 193).
The following table shows additional comparative values of relative spasmolytic activity between various tertiary amine compounds according to the present invention and papaverine. For the purpose of these tests the relative spasmolytic activity of papaverine hydrochloride was designated as being 1.0. These values were obtained by comparative tests on isolated guinea pig colons wherein spasms were induced with barium chloride. The testing procedure used to determine these values was that of Magnus (loc. cit.).
TABLE I Compound (as hydrochloride): fi fi g gjg ig Papaverine 1.0
1 (3,4 diethoxy phenyl) 1-di-ethy1amino-4- phenyl-butane 2.0
1-(4-n-propoxy-3-methoxy-phenyl) 1 dimethylamino-3-phenyl-propane 1.3
1 (4 methoxy-3-methyl-phenyl)-1-piperidyl- 2-phenyl-ethane 1.0
l-(3,4-diethoxy-phenyl)-1 dimethylamino 2- phenyl-ethane 1.0
1 (3,4 diethoxy phenyl)-1-diethylamino-3- methyl-3-phenyl-propane 2.0
l-(4-n-butoxy-3-methoxy phenyl) 1 dimethylamino-4-phenyl-butane 1.0
l (4 methoxy-3-methyl-phenyl)-1-dimethylamino-3-phenyl-propane 1.4
1-(4-methoxy-3-methyl-phenyl) 1 dimethylamino-2-phenyl-ethane 1.0
1 (4 methoxy-B-methyl-phenyl)-l-pyrrolidyl- 2-phenyl-ethane 1.0
1-(4-ethoxy-3-methoxy-phenyl) l pyrrolidyl- 4-phenyl-butane 1.3
1 (4 ethoxy-3-methoxy-phenyl)-1-piperidyl- 4-phenyl-butane 1.0
l-(2-ethoxy-3-methoxy-phenyl) 1 dimethylamino-4-phenyl-butane 1.0
1 (2 ethoxy 3 methoxy-phenyl)-1-diethylamino-3-methyl-3-phenyl-propane 1.0
1-(2,3-dimethoxy-phenyl) 1 dimethylamino- 4-phenyl-butane 0.8
TABLE ICntinued Compound (as hydrochloride): fifi i li fifi g 1 (2 methoxy phenyl)-1-dimethylamino-4- phenyl-butane 1.0 1-(2-methoxy-phenyl) 1 dimethylamino 3- methyl-3-phenyl-prop ane 1 .0 l (2,3 dimethoxy-phenyl)-l-dimethylamino- 3-methyl-3-phenyl-propane 0.8
Papaverine 1 (3,4 diethoxy phenyl)-1-dimethylamino-3 methyl-S-phenyl-propane 40 1-(4-ethoxy-3-methoxy phenyl) 1 diethylamino-4-phenyl-butane 45 l (4 ethoxy-3-methoxy-phenyl)-1-piperidyl- 3-methyl-3-phenyl-propane 45 1-(4-methoxy-3-methyl phenyl) 1 dimethylamino-3-phenyl-propane 50 1 (4 methoxy-3-ethoxy-phenyl)-1-dimethylamino-3-methyl-3-phenyl-propane 45 1-(4-methoxy-3-ethoxy phenyl) 1 diethylamino-4-phenyl-butane 54 1 (4 methoxy 3 ethoxy-phenyl)-1-diethylamino-3-methyl-3phenyl-propane 47 1-(3,4-diethoxy-phenyl) 1 dimethylamino-Z- phenyl-ethane 35 1 (4 methoxy 3 methyl-phenyl)-l-diethylamino-4-phenyl-butane 35 1-(3,4-diethoxy-phenyl) 1 diethylamino 3- methyl-3-phenyl-propane 45 1 (4 methoxy 3 ethoxy-phenyl)-1-dimethylamino-4-phenyl-butane 50 1-(3,4-diethoxy-phenyl) 1 diethylamino 3- phenyl-propane 55 l (2 ethoxy 3 methoxy-phenyl)-1-dimethylamino-4-phenyl-butane 53 1-(2-ethoxy 3 methoxy phenyl) 1 diethylamino-B-methyl-3-phenyl-propane 50 1 (2,3 dimethoxy phenyl)-l-dirnethylamino- 4-phenyl-butane 33 1-(2-methoxy phenyl) 1 dimethylamino 4- phenyl-butane -a 40 1 (2 methoxy phenyl)-1-dimethylamino-3- methyl-B-phenyl-propane 37 1-(2,3-dimethoxy phenyl) 1 dimethylamino- 3-methyl-3-phenyl-propane 30 Another surprising and useful property of certain compounds according to the present invention is the local anesthetic activity of those compounds having a lower alkoxy group attached to the phenyl radical which is attached to the carbon atom carrying the tertiary amino group. To demonstrate this surprising property, certain representative members of this group of compounds were subjected to comparative test with papaverine, using the method of Sollmann [Journal of Pharmacology, vol. 11, page 17 (1918)]. This test method comprises, in principle, placing a 1% aqueous solution of the compound in question on the cornea of the eye of a rabbit or similar test animal, and measuring the time during which there is no cornea reflex action. The following table shows the results of these tests.
TABLE III cgmpound Time period of absence (as hydrochloride): 1i3%ei Papaverine 0 1-(2-ethoxy 3 methoxy-phenyl)-1-dimethyla- :mino-4-phenyl-butane 120 1-(2 ethoxy-3-methoxy-phenyl) 1 diethylamino-3-rnethyl-3-phenyl-propane 15 1-(2,3 dimethoxy-phenyl)-1-dimethylamino-4- phenyl-butane 120 1-(2-methoxy-phenyl) 1 di-methylamino-4- phenyl butane 60 1-(2 methoxy-phenyl) 1 di-methylamino-3- methyl-3-phenyl-propane 20 '1-(2,3 dimethoxy-phenyl)-l-dimethylamino-3-- methyl-3-phenyl-propane 90 In addition, the Z-alkoxy-substituted compounds, administered in doses of 107 to 20 increase the flow of liquid through an isolated guinea pig heart, as determined by the method of Langendorif [Pfiugers Archiv, vol. 61 (1895), page 219] modified by Burn (Practical Pharmacology, Blackwell, Oxford, 1952, page 25).
Finally, 1-(2-n-propoxy-phenyl) 1 diethyla'mino-3- methyl-3-phenyl-propane hydrochloride was found to be spasmolytically 1.2 times more active than papaverine in an isolated guinea pig colon wherein spasms had been artificially induced with barium chloride. The compound was also twice as effective in dilating the arteria femoralis of anesthetized dogs than papaverine. Measurement of the coronary blood flow in dogs by the bubble-flow method also showed that this compound was 50% more effective than papaverine in its coronary dilating activity.
The data cited above make it abundantly clear that the compounds of the present invention have useful and effective pharmacological properties which are at least equal to and in many cases exceed the corresponding properties of the most common related pharmacological agent, papaverine. One specific group of these compou p is even exhibits pharmacological properties which papaverine does not have at all, namely local anesthetic activity.
While we have illustrated the present invention with the aid of certain specific embodiments thereof, it will be readily apparent to those skilled in the art that the invention is not limited to these embodiments, and that various changes and modifications may be made without departing from the spirit of the invention or the scope of the appended claims.
We claim:
1. l-(4-ethoxy-3-methoxy-phenyl) 1 dimethylamino- 4-phenyl-butane.
2. 1 (3,4 diethoxy-phenyl)-l-diethylaminot-phenylbutane.
3. 1-(4 lmethoxy-3-ethoxy-phenyl)-1-diethylamino-3- methyl-3-phenyl-propane.
4. 1-(3,4 dimethoxy-phenyl) 1 dimethylamino-4- phenyl-butane.
5. 1-(3,4 dimethoxy-phenyl) 1 dimethylamino-3- methyl 3-phenyl-propane.
6. 1-(3,4 dimethoxy-phenyl) -1-diethylarnino-4-phenylbutane.
References Cited in the file of this patent UNITED STATES PATENTS 2,276,587 Mettler et al Mar. 17, 1942 2,503,285 McPhee Apr. 11, 1950 2,504,122 Goodson et a1 Apr. 18, 1950 2,711,428 Goodson et al June 21, 1955 (Other references on following page) 3,133,967 19 7 20 FOREIGN PATENTS Goodson: Journal of the American Chemical Society,
vol. 72, pages 360-362 (1950).
Beilsteins Handbuch der Organischen Chemie,'vol. 13 1,008,740 Germany May 23, 1957 (211d supplement), Page 424 1,011,427 Germany July 4, 1957 5 Lettre et aL: Hoppe Seylers Zeitschrift fur PllYSlOlO- glsche Chenue, vol. 291, page 165 relied on (1952). OTHER REFERENCES Heinzelman et al.: Journal of the American Chemical Wittig et al.: Justus Liebigs Annalen, vol. 560, page Society, vol. 75, page 3410 relied on (1953). 117 (1948).
Claims (1)
1. 1-(4-ETHOXY-3-METHOXY-PHENYL) - 1 - DIMETHYLAMINO4-PHENYL-BUTANE.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6622A US3133967A (en) | 1960-02-04 | 1960-02-04 | 1-(3, 4-dialkoxy-phenol)-1-dialkylamino-3-and-4-piienyl butanes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6622A US3133967A (en) | 1960-02-04 | 1960-02-04 | 1-(3, 4-dialkoxy-phenol)-1-dialkylamino-3-and-4-piienyl butanes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3133967A true US3133967A (en) | 1964-05-19 |
Family
ID=21721785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US6622A Expired - Lifetime US3133967A (en) | 1960-02-04 | 1960-02-04 | 1-(3, 4-dialkoxy-phenol)-1-dialkylamino-3-and-4-piienyl butanes |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US3133967A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080132581A1 (en) * | 2004-05-28 | 2008-06-05 | Unigen Pharmaceuticals, Inc. | Diarylalkanes as potent inhibitors of binuclear enzymes |
| US20100016347A1 (en) * | 2008-07-21 | 2010-01-21 | Unigen Pharmaceuticals, Inc. | Series of skin whitening (lightening) compounds |
| US8586799B2 (en) | 2011-03-24 | 2013-11-19 | Unigen, Inc. | Compounds and methods for preparation of diarylpropanes |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB536881A (en) * | 1938-11-25 | 1941-05-30 | Geigy Ag J R | Process for the production of water-soluble high molecular ª‡-substituted aralkyl amines and derivatives thereof, and the resulting products |
| US2276587A (en) * | 1938-11-25 | 1942-03-17 | Geigy Ag J R | Water-soluble, high molecular alpha-substituted aralkyl amines and their manufacture |
| US2503285A (en) * | 1945-10-18 | 1950-04-11 | Winthrop Stearns Inc | Beta-substituted alpha, beta-diphenylethylamines and the preparation thereof |
| US2504122A (en) * | 1946-08-22 | 1950-04-18 | George A Breon & Company | Nu-allyl-1, 2-diphenylethylamine |
| US2711428A (en) * | 1948-11-19 | 1955-06-21 | George A Breon & Company | 1-(bicyclic carbocyclic aryl)-2-(monocyclic carbocyclic aryl) ethylamines |
| DE963424C (en) * | 1954-09-24 | 1957-05-09 | Thomae Gmbh Dr K | Process for the preparation of therapeutically active tertiary amines |
| DE1008740B (en) * | 1954-12-28 | 1957-05-23 | Thomae Gmbh Dr K | Process for the preparation of analgesic tertiary amines and their quaternary salts |
| DE1011427B (en) * | 1954-12-28 | 1957-07-04 | Thomae Gmbh Dr K | Process for the production of spasmolytic tertiary amines and their quaternary salts |
-
1960
- 1960-02-04 US US6622A patent/US3133967A/en not_active Expired - Lifetime
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB536881A (en) * | 1938-11-25 | 1941-05-30 | Geigy Ag J R | Process for the production of water-soluble high molecular ª‡-substituted aralkyl amines and derivatives thereof, and the resulting products |
| US2276587A (en) * | 1938-11-25 | 1942-03-17 | Geigy Ag J R | Water-soluble, high molecular alpha-substituted aralkyl amines and their manufacture |
| US2503285A (en) * | 1945-10-18 | 1950-04-11 | Winthrop Stearns Inc | Beta-substituted alpha, beta-diphenylethylamines and the preparation thereof |
| US2504122A (en) * | 1946-08-22 | 1950-04-18 | George A Breon & Company | Nu-allyl-1, 2-diphenylethylamine |
| US2711428A (en) * | 1948-11-19 | 1955-06-21 | George A Breon & Company | 1-(bicyclic carbocyclic aryl)-2-(monocyclic carbocyclic aryl) ethylamines |
| DE963424C (en) * | 1954-09-24 | 1957-05-09 | Thomae Gmbh Dr K | Process for the preparation of therapeutically active tertiary amines |
| DE1008740B (en) * | 1954-12-28 | 1957-05-23 | Thomae Gmbh Dr K | Process for the preparation of analgesic tertiary amines and their quaternary salts |
| DE1011427B (en) * | 1954-12-28 | 1957-07-04 | Thomae Gmbh Dr K | Process for the production of spasmolytic tertiary amines and their quaternary salts |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8729136B2 (en) | 2004-05-28 | 2014-05-20 | Unigen, Inc. | Diarylalkanes as potent inhibitors of binuclear enzymes |
| US9126913B2 (en) | 2004-05-28 | 2015-09-08 | Unigen, Inc. | Diarylalkanes as potent inhibitors of binuclear enzymes |
| US10548825B2 (en) | 2004-05-28 | 2020-02-04 | Unigen, Inc. | Diarylalkanes as potent inhibitors of binuclear enzymes |
| US7767661B2 (en) | 2004-05-28 | 2010-08-03 | Unigen Pharmaceuticals, Inc. | Diarylalkanes as potent inhibitors of binuclear enzymes |
| US20100267839A1 (en) * | 2004-05-28 | 2010-10-21 | Unigen Pharmaceuticals, Inc. | Diarylalkanes as potent inhibitors of binuclear enzymes |
| US8592488B2 (en) | 2004-05-28 | 2013-11-26 | Unigen, Inc. | Diarylalkanes as potent inhibitors of binuclear enzymes |
| US20080132581A1 (en) * | 2004-05-28 | 2008-06-05 | Unigen Pharmaceuticals, Inc. | Diarylalkanes as potent inhibitors of binuclear enzymes |
| EP1748767A4 (en) * | 2004-05-28 | 2008-12-24 | Unigen Pharmaceuticals Inc | DIARYLALCANES CONSTITUTING POWERFUL INHIBITORS OF BINUCLEAR ENZYMES |
| US8658838B2 (en) | 2008-07-21 | 2014-02-25 | Unigen, Inc. | Series of skin whitening (lightening) compounds |
| US9096507B2 (en) | 2008-07-21 | 2015-08-04 | Unigen, Inc. | Series of skin whitening (lightening) compounds |
| US8362305B2 (en) | 2008-07-21 | 2013-01-29 | Unigen, Inc. | Series of skin whitening (lightening) compounds |
| US20100016347A1 (en) * | 2008-07-21 | 2010-01-21 | Unigen Pharmaceuticals, Inc. | Series of skin whitening (lightening) compounds |
| US8586799B2 (en) | 2011-03-24 | 2013-11-19 | Unigen, Inc. | Compounds and methods for preparation of diarylpropanes |
| US9045405B2 (en) | 2011-03-24 | 2015-06-02 | Unigen, Inc. | Compounds and methods for preparation of diarylpropanes |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3974157A (en) | 1-(Amino-alkyl)-2-aryl-cyclohexane alcohols and esters | |
| US5036098A (en) | Butynylamine derivatives and their production | |
| PL90695B1 (en) | ||
| US3205136A (en) | Antidepressant phenyloxyalkylamines | |
| US3133967A (en) | 1-(3, 4-dialkoxy-phenol)-1-dialkylamino-3-and-4-piienyl butanes | |
| US4105695A (en) | 2-Amino-1-(2,5-dimethoxyphenyl)-butanes | |
| PT87503B (en) | METHOD FOR THE PREPARATION OF NEW CATECOLAMINE DERIVATIVES | |
| US3591634A (en) | N-(tertiary amino-alkyl)-benzamides | |
| US3772308A (en) | Cyclopentanecetamides and cyclopentaneacetonitriles | |
| US4107205A (en) | α-Aryl-α,α-bis[ω-(disubstituted amino)alkyl]acetamides and related compounds | |
| US3792053A (en) | 3-(1,2,3,4-tetrahydroisoquinolinomethyl)-3-quinuclidinol | |
| US2423025A (en) | Alkamine esters of diarylpropionic acids | |
| JPH036149B2 (en) | ||
| CA1129875A (en) | Chromone derivatives | |
| US4339576A (en) | Anti-asthmatic, anti-allergic, anti-cholinergic, bronchodilator and anti-inflammatory 1-[(benzoylphenyl)-lower-alkyl]piperidines and analogs thereof | |
| US2520179A (en) | 4-thiazolidones and a method for preparation thereof | |
| Leonard et al. | 2-Thenyl substituted diamines with antihistaminic activity | |
| US4259334A (en) | Piperazines and therapeutic utility | |
| US3423512A (en) | Treatment of emesis in mammals with substituted methylenedioxy benzamides | |
| US3668206A (en) | Heterocyclic amine derivatives of 5,8-dihydronaphthyloxy propanols | |
| US3723416A (en) | Substituted 2-arylalkyloxy benzamides | |
| US4058616A (en) | 2-[N-(1,3-diamino-isopropyl)-amino]-4-phenyl-2-imidazolines and salts thereof | |
| US2715645A (en) | N-aryl and n-aralkyl derivatives of n-dialkylaminoalkyl-aryloxyalkanoamides and methods for their production | |
| US4381313A (en) | Phenylalkanoic compounds and therapeutic use thereof | |
| EP0137426A2 (en) | 2-Mercaptothiazole derivatives, process for their preparation and utilization of 2-mercaptothiazole derivatives in pharmaceutical compounds |